- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
This study will evaluate the safety, tolerability and efficacy of multiple doses of AFQ056 in patients with Fragile X Syndrome. The dose range will be 50 to 150 mg b.i.d. The primary read-out of efficacy is reduction in Aberrant-Behavior Checklist score.
Critère d'inclusion
- Fragile X syndrome